3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
7
Recurrence
1
Non-Muscle Invasive Bladder Neoplasms
1
Interventions
Dexamethasone
28
Rituximab
16
pomalidomide
14
Gemcitabine
12
Bortezomib
12
Lenalidomide
11
Cisplatin
11
Paclitaxel
10
Cyclophosphamide
8
Carboplatin
8
carfilzomib
7
daratumumab
6
selinexor
5
Drug Therapy
5
Doxorubicin
5
Cytarabine
5
ibrutinib
4
Vincristine
4
Temozolomide
4
Prednisone
4
Docetaxel
4
Calcium Dobesilate
4
Bevacizumab
4
Aspirin
4
tisagenlecleucel
3
Injections
3
Cetuximab
3
Bendamustine Hydrochloride
3
venetoclax
2
ofatumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Recurrence
×
5-aminolevulinic acid hexyl ester
×
Clear all
NCT02660190
2019-08-14
DaBlaCa-11
Aarhus University Hospital
Phase 3
Completed
696 enrolled